title: Evidence for a respiration-modulated cholinergic action on the activity of medullary respiration-related neurons in the rabbit. An iontophoretic study.
abstract: Effects of the iontophoretically administered cholinergic agonists acetylcholine, bethanechol and DMPP on the activity of medullary respiration-related neurons were examined in urethane-anaesthetized rabbits. Inhibitory effects prevailed over excitatory effects. Analysis of cholinergic effects by cycle-triggered averaging revealed three major types of neuronal responses: (i) constant alterations of spike-density throughout the whole period of activity ("constant effects"), (ii) effects increasing during the progression of the burst of discharge or effects restricted to a particular fraction of the burst ("phasic effects") and (iii) effects which were characterized by an excitation during one respiratory phase and an inhibition during the other phase ("bi-phasic effects"). The latter type of effects was observed in phase-spanning respiration-related neurons. Phasic effects were mainly observed in inspiration-related neurons which were predominantly inhibited by stimulation of muscarinic receptors. Inspiratory R beta-neurons in no case were phasically affected by cholinergic agents. The mean muscarinic inhibition of inspiration-related neurons increased with the progression of inspiration. The mean nicotinic inhibition of expiration-related neurons decreased with the progression of expiration. Results suggest that the efficacy of (i) a central inspiration terminating mechanism and (ii) the onset of discharge of expiratory neurons is modulated by acetylcholine.
authors.affiliation: Department of Physiology, University of Mainz, Federal Republic of Germany.
authors.forename: G
authors.initials: G
authors.lastname: Böhmer
authors.forename: K
authors.initials: K
authors.lastname: Schmid
authors.forename: M
authors.initials: M
authors.lastname: Baumann
mesh_terms: D000109:Acetylcholine / Q000008:administration & dosage / Q000494:pharmacology / Q000502:physiology*; D000200:Action Potentials / Q000187:drug effects / Q000502:physiology; D000818:Animals; D018723:Bethanechol; D001626:Bethanechol Compounds / Q000008:administration & dosage / Q000494:pharmacology; D004246:Dimethylphenylpiperazinium Iodide / Q000008:administration & dosage / Q000494:pharmacology; D004594:Electrophysiology; D018738:Hexamethonium; D006584:Hexamethonium Compounds / Q000494:pharmacology; D007478:Iontophoresis; D009474:Neurons / Q000187:drug effects / Q000502:physiology*; D011817:Rabbits; D011976:Receptors, Muscarinic / Q000502:physiology; D012119:Respiration / Q000502:physiology*; D012137:Respiratory System / Q000294:innervation*
chemical_list: D001626:Bethanechol Compounds; D006584:Hexamethonium Compounds; D011976:Receptors, Muscarinic; D018723:Bethanechol; D018738:Hexamethonium; D004246:Dimethylphenylpiperazinium Iodide; D000109:Acetylcholine